Calls to make drugs for rare conditions available
The Muscular Dystrophy Campaign is supporting the calls of a number of leading neuromuscular clinicians for changes to the regulations on orphan drugs – treatments for very rare conditions – to ensure that patients with these conditions have access to available, cost-effective treatments.
The British Medical Journal has today published an open letter from the clinicians to the Prime Minister and Health Secretary expressing their concerns that the current system pushes up the cost of orphan drugs, and does not work in the best interest of patients with very rare conditions.
Read the full story and letter